Amorepacific Partners with Higher Corporation to Develop Integrated Beauty Solutions

By Hong Seungwan Posted : July 27, 2026, 16:52 Updated : July 27, 2026, 16:52

Amorepacific Holdings has made a strategic investment in Higher Corporation, a company specializing in aesthetic medical devices, to enhance collaboration in the beauty and medical sectors.

On July 27, Amorepacific Holdings announced that it has signed an investment agreement with Higher Corporation to strengthen their partnership in the beauty and medical fields. The two companies plan to combine Higher Corporation's expertise in developing aesthetic medical devices with Amorepacific's dermatological research and skincare technology, leveraging a global network of key opinion leaders (KOLs) in the medical field.

The collaboration will encompass product planning, research and development (R&D), distribution, and marketing. Key areas of focus will include the development and commercialization of skin boosters, cosmeceuticals, and medical devices. They will also work together on developing aftercare products, distribution to hospitals and clinics, and joint research and marketing activities for raw materials and ingredients.

In particular, the two companies aim to concentrate on developing integrated beauty solutions that connect professional treatments with everyday skincare. Lee Sang-mok, CEO of Amorepacific Holdings, stated, "We will develop next-generation beauty solutions that combine dermatological science and medical device technology to provide new customer experiences in the global beauty and medical market."

Kim In-yong, CEO of Higher Corporation, remarked, "This agreement marks the starting point for combining Higher Corporation's accumulated expertise in medical aesthetics with Amorepacific's research capabilities to create next-generation beauty and medical solutions together."

Meanwhile, Lee is scheduled to attend the Korea-Brazil Business Roundtable in São Paulo on the 28th (local time) during President Lee Jae-myung's visit to Brazil.




* This article has been translated by AI.

Copyright ⓒ Aju Press All rights reserved.